Development of a Biosafety Enhanced and Immunogenic Salmonella Enteritidis Ghost Using an Antibiotic Resistance Gene Free Plasmid Carrying a Bacteriophage Lysis System

In the development of genetically inactivated bacterial vaccines, plasmid retention often requires the antibiotic resistance gene markers, the presence of which can cause the potential biosafety hazards such as the horizontal spread of resistance genes. The new lysis plasmid was constructed by utilizing the approach of balanced-lethal systems based on auxotrophic gene Aspartate semialdehyde dehydrogenase (asd). The PhiX174 lysis gene E and λPR37-cI857 temperature-sensitive regulatory system was cloned in the asd gene positive plasmid and this novel approach allowed the production of antibiotic resistance marker free Salmonella Enteritidis (S. Enteritidis) ghost. The immunogenic potential of the biosafety enhanced antibiotic resistance gene free S. Enteritidis ghost was evaluated in chickens by employing the prime-boost vaccination strategy using a combination of oral and intramuscular routes. A total of 75 two-week-old chickens were equally divided into five groups: group A (non-immunized control), group B (intramuscularly primed and boosted), group C (primed intramuscularly and boosted orally), group D (primed and boosted orally), and group E (primed orally and boosted intramuscularly). Chickens from all immunized groups demonstrated significant increases in plasma IgG, intestinal secretory IgA levels, and antigen-specific lymphocyte proliferative response. After a virulent S. Enteritidis challenge, all immunized groups showed fewer gross lesions and decreased bacterial recovery from organs in comparison with the non-immunized control group. Among the immunized chickens, groups B and D chickens showed optimized protection, indicating that the prime-booster immunization with the ghost via intramuscular or oral route is efficient. Taken together, our results demonstrate that an antibiotic resistance gene free lysis plasmid was successfully constructed and utilized for production of safety enhanced S. Enteritidis ghost, which can be used as a safe and effective vaccine against virulent S. Enteritidis infections.

[1]  F. Sanger,et al.  Nucleotide sequence of bacteriophage φX174 DNA , 1977, Nature.

[2]  F. Sanger,et al.  Nucleotide sequence of bacteriophage phi X174 DNA. , 1977, Nature.

[3]  H. Jörnvall,et al.  Aspartate-beta-semialdehyde dehydrogenase from Escherichia coli. Purification and general properties. , 1980, European journal of biochemistry.

[4]  T. Eisenstein,et al.  Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection. , 1984, The Journal of infectious diseases.

[5]  R. Curtiss,et al.  Construction of an ASD+ Expression-Cloning Vector: Stable Maintenance and High Level Expression of Cloned Genes in a Salmonella Vaccine Strain , 1988, Bio/Technology.

[6]  W. Bentley,et al.  Plasmid‐encoded protein: The principal factor in the “metabolic burden” associated with recombinant bacteria , 1990, Biotechnology and bioengineering.

[7]  A. Villaverde,et al.  Fine regulation of cI857-controlled gene expression in continuous culture of recombinant Escherichia coli by temperature , 1993, Applied and environmental microbiology.

[8]  A. Hensel,et al.  Bacterial ghosts: non-living candidate vaccines. , 1996, Journal of biotechnology.

[9]  S. Ahmed,et al.  Analysis of avian lymphocyte proliferation by a new, simple, nonradioactive assay (lympho-pro). , 1997, Avian diseases.

[10]  F. Baneyx.  Recombinant protein expression in Escherichia coli. , 1999, Current opinion in biotechnology.

[11]  J. Davison,et al.  Genetic exchange between bacteria in the environment. , 1999, Plasmid.

[12]  S. Fürst-Ladani,et al.  Activation, stimulation and uptake of bacterial ghosts in antigen presenting cells. , 2000, Journal of biotechnology.

[13]  R. Young,et al.  Genetic evidence that the bacteriophage phi X174 lysis protein inhibits cell wall synthesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Hensel,et al.  Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state. , 2000, Vaccine.

[15]  M. Jenkins,et al.  Serovar Typhimurium Enterica Salmonella Virulent but Not Attenuated Antibody Is Required for Protection Against , 2000 .

[16]  P. Ogra,et al.  Vaccination Strategies for Mucosal Immune Responses , 2001, Clinical Microbiology Reviews.

[17]  A. Hensel,et al.  Bacterial ghosts as vaccine candidates for veterinary applications. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Donna J. Freeman,et al.  Attenuated Salmonella enterica Serovar Typhi Expressing Urease Effectively Immunizes Mice against Helicobacter pylori Challenge as Part of a Heterologous Mucosal Priming-Parenteral Boosting Vaccination Regimen , 2002, Infection and Immunity.

[19]  P. Payette,et al.  Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA. , 2002, FEMS immunology and medical microbiology.

[20]  R. Curtiss,et al.  Immune Responses to Recombinant Pneumococcal PspA Antigen Delivered by Live Attenuated Salmonella enterica Serovar Typhimurium Vaccine , 2002, Infection and Immunity.

[21]  W. Lubitz,et al.  Escherichia coli Ghost Production by Expression of Lysis Gene E and Staphylococcal Nuclease , 2003, Applied and Environmental Microbiology.

[22]  M. Rohde,et al.  Generation of Helicobacter pylori Ghosts by PhiX Protein E-Mediated Inactivation and Their Evaluation as Vaccine Candidates , 2003, Infection and Immunity.

[23]  W. Lubitz,et al.  Pasteurella multocida- and Pasteurella haemolytica-ghosts: new vaccine candidates. , 2003, Vaccine.

[24]  A. Rementeria,et al.  Development of a Multiplex PCR Technique for Detection and Epidemiological Typing of Salmonella in Human Clinical Samples , 2004, Journal of Clinical Microbiology.

[25]  W. Lubitz,et al.  Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli , 2004, Archives of Microbiology.

[26]  A. Atrasheuskaya,et al.  Bacterial Ghosts as an Oral Vaccine: a Single Dose of Escherichia coli O157:H7 Bacterial Ghosts Protects Mice against Lethal Challenge , 2005, Infection and Immunity.

[27]  Dong Soo Kim,et al.  Generation of Edwardsiella tarda ghosts by bacteriophage PhiX174 lysis gene E , 2005 .

[28]  J. Wood,et al.  Effect of immune serum and role of individual Fcγ receptors on the intracellular distribution and survival of Salmonella enterica serovar Typhimurium in murine macrophages , 2006, Immunology.

[29]  N. Rana,et al.  Cell-mediated and humoral immune responses to a virulent plasmid-cured mutant strain of Salmonella enterica serotype gallinarum in broiler chickens. , 2006, Veterinary microbiology.

[30]  P. González,et al.  T cell immunity evasion by virulent Salmonella enterica. , 2007, Immunology letters.

[31]  P. Barrow.  Salmonella infections: immune and non-immune protection with vaccines , 2007, Avian pathology : journal of the W.V.P.A.

[32]  Eun Hye Lee,et al.  Generation of safety enhanced Edwardsiella tarda ghost vaccine. , 2008, Diseases of aquatic organisms.

[33]  R. Beal,et al.  The avian enteric immune system in health and disease , 2008, Avian Immunology.

[34]  Eun Hye Lee,et al.  Generation of Vibrio anguillarum Ghost by Coexpression of PhiX 174 Lysis E gene and Staphylococcal Nuclease A Gene , 2009, Molecular biotechnology.

[35]  D. Klinkenberg,et al.  Quantification of Horizontal Transmission of Salmonella enterica Serovar Enteritidis Bacteria in Pair-Housed Groups of Laying Hens , 2009, Applied and Environmental Microbiology.

[36]  Xuepeng Wang,et al.  Mice orally vaccinated with Edwardsiella tarda ghosts are significantly protected against infection. , 2009, Vaccine.

[37]  P. Kaiser,et al.  The immunobiology of avian systemic salmonellosis. , 2009, Veterinary immunology and immunopathology.

[38]  S. Choi,et al.  Novel Expression System for Combined Vaccine Production in Edwardsiella tarda Ghost and Cadaver Cells , 2010, Molecular biotechnology.

[39]  Aamir Fazil,et al.  The global burden of nontyphoidal Salmonella gastroenteritis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  John-hwa Lee,et al.  Physiology, pathogenicity and immunogenicity of lon and/or cpxR deleted mutants of Salmonella Gallinarum as vaccine candidates for fowl typhoid , 2010, Veterinary research.

[41]  Wei Si,et al.  Enhancement of bacteriolysis of Shuffled phage PhiX174 gene E , 2011, Virology Journal.

[42]  M. Levine,et al.  Immunology of gut mucosal vaccines , 2011, Immunological reviews.

[43]  Siguo Liu,et al.  Salmonella enteritidis ghost vaccine induces effective protection against lethal challenge in specific-pathogen-free chicks. , 2011, Immunobiology.

[44]  R. Nandre,et al.  Immunogenicity of a Salmonella Enteritidis mutant as vaccine candidate and its protective efficacy against salmonellosis in chickens. , 2011, Veterinary immunology and immunopathology.

[45]  John-hwa Lee,et al.  Evaluation of safety and protection efficacy on cpxR and lon deleted mutant of Salmonella Gallinarum as a live vaccine candidate for fowl typhoid. , 2011, Vaccine.

[46]  John-hwa Lee,et al.  Construction of a Salmonella Gallinarum ghost as a novel inactivated vaccine candidate and its protective efficacy against fowl typhoid in chickens , 2012, Veterinary Research.

[47]  R. Nandre,et al.  Characterization of a Novel Inactivated Salmonella enterica Serovar Enteritidis Vaccine Candidate Generated Using a Modified cI857/λ PR/Gene E Expression System , 2012, Infection and Immunity.

[48]  N. Shen,et al.  Protection of Piglets by a Haemophilus parasuis Ghost Vaccine against Homologous Challenge , 2013, Clinical and Vaccine Immunology.

[49]  Shiyun Chen,et al.  Yersinia enterocolitica ghost with msbB mutation provides protection and reduces proinflammatory cytokines in mice. , 2013, Vaccine.